innovator multiple source drug

(ii)The term “innovator multiple source drug” means a multiple source drug that is marketed under a new drug application approved by the Food and Drug Administration, unless the Secretary determines that a narrow exception applies (as described in(or any successor regulation)).

Source

42 USC § 1396r-8(k)(7)(A)(ii)


Scoping language

In this section
Is this correct? or